Download PDF
Thromb Haemost
DOI: 10.1055/a-2513-9638
Stroke, Systemic or Venous Thromboembolism

Monocyte/Macrophage Infiltration in Thrombus and Outcomes of Stroke Patients with Monocyte/Macrophage-dominant Thrombus

Kijeong Lee
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Myoung-Jin Cha
2   Department of Neurology, National Police Hospital, Seoul, South Korea
,
Il Kwon
3   Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, South Korea
,
Sungeun Kim
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Jin Ju Song
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Young Dae Kim
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Hyo Suk Nam
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Jaseong Koo
4   Department of Neurology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea
,
Hye Sun Lee
5   Biostatistics Collaboration Unit, Department of Research Affairs, Yonsei University College of Medicine, Seoul, South Korea
,
Haram Joo
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
,
Hyunjung Choi
6   GlaxoSmithKline (GSK) Plc., Philadelphia, United States
,
Ji Hoe Heo
1   Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
3   Integrative Research Center for Cerebrovascular and Cardiovascular Diseases, Yonsei University College of Medicine, Seoul, South Korea
› Author Affiliations Funding This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (RNF-2021R1A2C2003658) and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (RS-2023–00265497).
› Further Information
Also available at
    Permissions and Reprints


Abstract

Background Inflammatory cells may play a role in thrombus formation. However, the impact of monocytes in thrombosis and clinical characteristics of patients with monocyte-rich thrombus are less well understood.

Methods A FeCl3-induced carotid thrombosis model in mice was used to study aged thrombus by ligating the distal carotid artery for 0.5, 1, 2, 3, 6, 24, 48, or 72 hours. In stroke patients, we used thrombi that were obtained during endovascular thrombectomy. Immunohistochemistry was performed to determine thrombus composition. We investigated monocyte/macrophage recruitment to arterial thrombus over time in mice, and compared clinical outcomes between stroke patients with the higher and the lower monocyte/macrophage compositions in thrombus.

Results In 90 mice, CD68 (monocyte/macrophage) counts increased from 3 hours in a time-dependent manner, and decreased after 48 hours (p < 0.001). In 102 stroke patients, the higher monocyte/macrophage group had higher blood platelet counts (median 228 × 109/L, interquartile range [177–267] versus median 186 × 109/L, interquartile range [164–225], p = 0.036), less frequently parenchymal hematoma (8.0% versus 28.8%, p = 0.007), and more frequently functional independence (54.0% versus 32.7%, p = 0.030). In multivariable logistic regression analysis, the higher monocyte/macrophage group was independently associated with functional independence (odds ratio 4.954, 95% confidence interval 1.467–16.724, p = 0.010).

Conclusion Monocytes/macrophages increasingly infiltrated the thrombus after a few hours in mouse arterial thrombosis model, suggesting their role in later stages rather than initial stages of thrombosis. Stroke patients with higher monocyte/macrophage counts had less frequent parenchymal hematoma and more frequent functional independence, suggesting that monocyte/macrophage-rich thrombi are a predictor of better clinical outcomes.

Keywords

monocyte/macrophage - thrombosis - stroke - endovascular thrombectomy - functional outcome

Supplementary Material



Publication History

Received: 07 July 2024

Accepted: 09 January 2025

Article published online:
17 February 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13 (01) 34-45
    CrossrefPubMedSearch in Google Scholar
  • 2 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019; 45 (01) 86-93
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Goyal M, Menon BK, van Zwam WH. et al; HERMES collaborators. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387 (10029): 1723-1731
    CrossrefPubMedSearch in Google Scholar
  • 4 Heo JH, Nam HS, Kim YD. et al. Pathophysiologic and therapeutic perspectives based on thrombus histology in stroke. J Stroke 2020; 22 (01) 64-75
    CrossrefPubMedSearch in Google Scholar
  • 5 Riegger J, Byrne RA, Joner M. et al; Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort (PRESTIGE) Investigators. Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium. Eur Heart J 2016; 37 (19) 1538-1549
    CrossrefPubMedSearch in Google Scholar
  • 6 Cha MJ, Ha J, Lee H. et al. Neutrophil recruitment in arterial thrombus and characteristics of stroke patients with neutrophil-rich thrombus. Yonsei Med J 2022; 63 (11) 1016-1026
    CrossrefPubMedSearch in Google Scholar
  • 7 Boeckh-Behrens T, Schubert M, Förschler A. et al. The impact of histological clot composition in embolic stroke. Clin Neuroradiol 2016; 26 (02) 189-197
    CrossrefPubMedSearch in Google Scholar
  • 8 Radzyukevich YV, Kosyakova NI, Prokhorenko IR. Participation of monocyte subpopulations in progression of experimental endotoxemia (EE) and systemic inflammation. J Immunol Res 2021; 2021: 1762584
    CrossrefPubMedSearch in Google Scholar
  • 9 Tutwiler V, Madeeva D, Ahn HS. et al. Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. Blood 2016; 127 (04) 464-472
    CrossrefPubMedSearch in Google Scholar
  • 10 von Brühl ML, Stark K, Steinhart A. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209 (04) 819-835
    CrossrefPubMedSearch in Google Scholar
  • 11 Kwon I, Hong SY, Kim YD. et al. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice. PLoS One 2013; 8 (11) e81165
    CrossrefPubMedSearch in Google Scholar
  • 12 Shim Y, Kwon I, Park Y. et al. Characterization of ferric chloride-induced arterial thrombosis model of mice and the role of red blood cells in thrombosis acceleration. Yonsei Med J 2021; 62 (11) 1032-1041
    CrossrefPubMedSearch in Google Scholar
  • 13 Park H, Kim J, Ha J. et al. Histological features of intracranial thrombi in stroke patients with cancer. Ann Neurol 2019; 86 (01) 143-149
    CrossrefPubMedSearch in Google Scholar
  • 14 Heo J, Seog Y, Lee H. et al. Automated composition analysis of thrombus from endovascular treatment in acute ischemic stroke using computer vision. J Stroke 2022; 24 (03) 433-435
    CrossrefPubMedSearch in Google Scholar
  • 15 Heo J, Lee H, Seog Y. et al. Cancer prediction with machine learning of thrombi from thrombectomy in stroke: multicenter development and validation. Stroke 2023; 54 (08) 2105-2113
    CrossrefPubMedSearch in Google Scholar
  • 16 Rittersma SZ, van der Wal AC, Koch KT. et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005; 111 (09) 1160-1165
    CrossrefPubMedSearch in Google Scholar
  • 17 Adams Jr HP, Bendixen BH, Kappelle LJ. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (01) 35-41
    CrossrefPubMedSearch in Google Scholar
  • 18 Higashida RT, Furlan AJ, Roberts H. et al; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34 (08) e109-e137
    CrossrefPubMedSearch in Google Scholar
  • 19 Yaghi S, Willey JZ, Cucchiara B. et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Quality of Care and Outcomes Research. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2017; 48 (12) e343-e361
    CrossrefPubMedSearch in Google Scholar
  • 20 Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res 2014; 2 (01) 1
    CrossrefPubMedSearch in Google Scholar
  • 21 Han Z, Liu Q, Li H. et al. The role of monocytes in thrombotic diseases: a review. Front Cardiovasc Med 2023; 10: 1113827
    CrossrefPubMedSearch in Google Scholar
  • 22 Frantz S, Hofmann U, Fraccarollo D. et al. Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. FASEB J 2013; 27 (03) 871-881
    CrossrefPubMedSearch in Google Scholar
  • 23 Lambert JM, Lopez EF, Lindsey ML. Macrophage roles following myocardial infarction. Int J Cardiol 2008; 130 (02) 147-158
    CrossrefPubMedSearch in Google Scholar
  • 24 Troidl C, Möllmann H, Nef H. et al. Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction. J Cell Mol Med 2009; 13 (9B): 3485-3496
    CrossrefPubMedSearch in Google Scholar
  • 25 Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2013; 229 (02) 176-185
    CrossrefPubMedSearch in Google Scholar
  • 26 Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454 (7203): 428-435
    CrossrefPubMedSearch in Google Scholar
  • 27 Nicklas JM, Gordon AE, Henke PK. Resolution of deep venous thrombosis: proposed immune paradigms. Int J Mol Sci 2020; 21 (06) 2080
    CrossrefPubMedSearch in Google Scholar
  • 28 Bystrom J, Evans I, Newson J. et al. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 2008; 112 (10) 4117-4127
    CrossrefPubMedSearch in Google Scholar
  • 29 Ali T, Humphries J, Burnand K. et al. Monocyte recruitment in venous thrombus resolution. J Vasc Surg 2006; 43 (03) 601-608
    CrossrefPubMedSearch in Google Scholar
  • 30 Kaesmacher J, Boeckh-Behrens T, Simon S. et al. Risk of thrombus fragmentation during endovascular stroke treatment. AJNR Am J Neuroradiol 2017; 38 (05) 991-998
    CrossrefPubMedSearch in Google Scholar
  • 31 Ye G, Qi P, Chen K. et al. Risk of secondary embolism events during mechanical thrombectomy for acute ischemic stroke: a single-center study based on histological analysis. Clin Neurol Neurosurg 2020; 193: 105749
    CrossrefPubMedSearch in Google Scholar
  • 32 Baek J-H, Kwon I, Kim S. et al. Histological determination of thrombus fragility in endovascular thrombectomy for acute stroke. J Stroke 2024
    PubMedSearch in Google Scholar
  • 33 Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172 (05) 2731-2738
    CrossrefPubMedSearch in Google Scholar
  • 34 Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68/macrosialin: not just a histochemical marker. Lab Invest 2017; 97 (01) 4-13
    CrossrefPubMedSearch in Google Scholar